# China SXT Pharmaceuticals, Inc. (SXTC)

> Healthcare · CN · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SXTC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.08M | $ -6.12M | $ -5.15M | $ 1.12M | $ 29.71M |
| 2025 | $ 1.78M | $ -3.38M | $ -2.12M | $ 983.9K | $ 15.44M |
| 2024 | $ 6.83M | $ -3.26M | $ -1.88M | $ 2.65M | $ 13.93M |
| 2023 | $ 3.26M | $ -7.23M | $ -823.6K | $ 3.76M | $ 14.69M |
| 2022 | $ 9.23M | $ -9.61M | $ -2.35M | $ 10.74M | $ 16.42M |
| 2021 | $ 11.23M | $ -3.27M | $ -908.4K | N/A | $ 15.96M |
| 2020 | $ 8.62M | $ -22.65M | $ 1.29M | $ 6.72M | $ 9.40M |
| 2019 | $ 9.05M | $ 4.26M | $ -464.2K | $ 2.79M | $ 11.11M |
| 2018 | $ 14.41M | $ 2.61M | $ 1.46M | $ 385.1K | $ 3.29M |
| 2017 | $ 1.55M | $ 504.9K | $ 58.6K | $ 302.2K | $ 1.85M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.17 |
| Current Ratio | 7.93 |

## Other views

- [Metrics](https://sponda.capital/en/SXTC.md)
- [Charts](https://sponda.capital/en/SXTC/charts.md)
- [Compare](https://sponda.capital/en/SXTC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.